BioCentury | May 12, 2008
Company News

DxTech LLC, Nicholas Piramal India Ltd. deal

...the diagnostic in the U.S. and India by late 2009. DxTech LLC , Merrimack, N.H. Nicholas Piramal India Ltd....
BioCentury | Feb 25, 2008
Strategy

Offloading R&D in India

...this year. This is a path that Sun Pharmaceuticals Industries Ltd. has already trodden and Nicholas Piramal India Ltd....
...Dr. Reddy's Laboratories Ltd. (NYSE: RDY; BSE:DRREDDY), Hyderabad, India GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Nicholas Piramal India Ltd....
BioCentury | Feb 4, 2008
Company News

Pierre Fabre, Nicholas Piramal India Ltd. deal

...natural products library. Further terms were not disclosed. Laboratoires Pierre Fabre S.A. , Castres, France Nicholas Piramal India Ltd....
BioCentury | Dec 3, 2007
Strategy

Piramal's second helping

...When Nicholas Piramal India Ltd. established its discovery business two years ago, it set itself the goal of bringing...
BioCentury | Dec 3, 2007
Company News

Merck, Nicholas Piramal India Ltd. deal

...million in milestones per target, plus royalties. Merck & Co. Inc. (MRK), Whitehouse Station, N.J. Nicholas Piramal India Ltd....
BioCentury | Jan 29, 2007
Strategy

No money down

...they go to companies in Asia. Eli Lilly and Co. has announced a deal with Nicholas Piramal India Ltd....
BioCentury | Jan 29, 2007
Company News

Napo, Nicholas Piramal India Ltd. deal

...II diabetes and metabolic disease this year. Napo Pharmaceuticals Inc. (LSE:NAPL), South San Francisco, Calif. Nicholas Piramal India Ltd....
BioCentury | Jan 22, 2007
Company News

Eli Lilly, Nicholas Piramal India Ltd. deal

...molecule, and LLY would be eligible for royalties. Eli Lilly and Co. (LLY), Indianapolis, Ind. Nicholas Piramal India Ltd....
BioCentury | Jul 18, 2005
Company News

BioSyntech, Nicholas Piramal India Ltd. deal

...purchase will give Nicholas Piramal a 17% stake in BSY. BioSyntech Inc. (TSE:BSY), Laval, Quebec Nicholas Piramal India Ltd....
Items per page:
1 - 9 of 9
BioCentury | May 12, 2008
Company News

DxTech LLC, Nicholas Piramal India Ltd. deal

...the diagnostic in the U.S. and India by late 2009. DxTech LLC , Merrimack, N.H. Nicholas Piramal India Ltd....
BioCentury | Feb 25, 2008
Strategy

Offloading R&D in India

...this year. This is a path that Sun Pharmaceuticals Industries Ltd. has already trodden and Nicholas Piramal India Ltd....
...Dr. Reddy's Laboratories Ltd. (NYSE: RDY; BSE:DRREDDY), Hyderabad, India GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Nicholas Piramal India Ltd....
BioCentury | Feb 4, 2008
Company News

Pierre Fabre, Nicholas Piramal India Ltd. deal

...natural products library. Further terms were not disclosed. Laboratoires Pierre Fabre S.A. , Castres, France Nicholas Piramal India Ltd....
BioCentury | Dec 3, 2007
Strategy

Piramal's second helping

...When Nicholas Piramal India Ltd. established its discovery business two years ago, it set itself the goal of bringing...
BioCentury | Dec 3, 2007
Company News

Merck, Nicholas Piramal India Ltd. deal

...million in milestones per target, plus royalties. Merck & Co. Inc. (MRK), Whitehouse Station, N.J. Nicholas Piramal India Ltd....
BioCentury | Jan 29, 2007
Strategy

No money down

...they go to companies in Asia. Eli Lilly and Co. has announced a deal with Nicholas Piramal India Ltd....
BioCentury | Jan 29, 2007
Company News

Napo, Nicholas Piramal India Ltd. deal

...II diabetes and metabolic disease this year. Napo Pharmaceuticals Inc. (LSE:NAPL), South San Francisco, Calif. Nicholas Piramal India Ltd....
BioCentury | Jan 22, 2007
Company News

Eli Lilly, Nicholas Piramal India Ltd. deal

...molecule, and LLY would be eligible for royalties. Eli Lilly and Co. (LLY), Indianapolis, Ind. Nicholas Piramal India Ltd....
BioCentury | Jul 18, 2005
Company News

BioSyntech, Nicholas Piramal India Ltd. deal

...purchase will give Nicholas Piramal a 17% stake in BSY. BioSyntech Inc. (TSE:BSY), Laval, Quebec Nicholas Piramal India Ltd....
Items per page:
1 - 9 of 9